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ABSTRACT
HYPOXIC AND VIRAL CONTRIBUTIONS TO THE ETIOPATHOGENESIS OF
SCHIZOPHRENIA: A WHOLE TRANSCRIPTOME ANALYSIS
by
Kathryn A. Gorski
Schizophrenia is a mental illness with a complex and as of yet unclear etiology. It is
highly heritable and has a strong polygenic character, however, studies examining the
genetics of schizophrenia have not sufficiently explained all variability in its prevalence.
Environmental causes are theorized to have a non trivial contribution to the pathoetiology
of schizophrenia, including interactions with genetic components, but these mechanisms
remain unclear. Analyzing schizophrenia dysfunction using transcriptomic approaches is
a paradigm still in its infancy, and fewer studies still have examined non neurological
contributions to schizophrenia pathology with next generation sequencing technologies.
This  pilot  study uses  several  tools  to  probe  changes  in  gene  expression  and isoform
prevalence,  and  to  detect  the  presence  of  viral  genomes  that  may  contribute  to
schizophrenia  pathoetiology.  Findings  of  interest  include  a  robust  genetic  response
associated with hypoxia and downstream changes in gene expression that may have direct
consequences  on schizophrenia symptomatology,  and the presence of viral  transcripts
suggesting an active viral infection in a schizophrenic patient. While these findings are
not  definitive  proof  that  these  events  are  directly  correlated  with  schizophrenia
pathoetiology, they suggest intriguing directions to pursue in next generation sequencing
research to clarify this complex disorder. 
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CHAPTER 1
INTRODUCTION
Schizophrenia is a chronic and severe mental illness that carries a high global burden,
with a large economic impact due to the cost of medical care and social support and the
indirect  cost  resulting  from  productivity  loss,  premature  mortality  and  other  factors
(Chong et al.,  2016). The disorder has a lifetime prevalence of approximately 4.0 per
1000 persons, and while it is not a culture bound syndrome, the presentation of symptoms
differs from culture to culture (Saha et al., 2005). It is formally diagnosed by the presence
of  both  positive  symptoms  (delusions,  hallucinations,  and  disorganized  speech)  and
negative symptoms (including avolition and affective flattening); these symptoms must
cause dysfunction in the patient’s daily life (Tandon et  al.,  2013).  Schizophrenia was
formerly  categorized  into  paranoid,  catatonic,  disorganized,  and  undifferentiated
subtypes, reflecting its highly heterogeneous character and presentation (Tandon et al.,
2013). 
The  leading  theory  of  neurobiological  schizophrenia  pathoetiology  is  the
dysregulation of dopamine and glutamate pathways in the brain (Howes et al.,  2015).
Early studies of schizophrenia implicated the dopamine receptor D2 as a central point of
dysfunction. Schizophrenic brains post-mortem show increased D2 receptor density, and
genetic studies demonstrate that changes in the gene coding for D2, DRD2, are associated
with schizophrenia (Howes et al., 2015). Recent work has implicated glutamate signaling
and the NMDA (N-methyl-D-aspartate) receptor as foci of interest, relating to alterations
in  GABA  (γ-aminobutyric  acid)  interneurons;  changes  in  the  GABAergic  system
potentially contribute to dopaminergic pathway dysregulation (Cohen et al., 2015). 
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1.1 Genetic and Environmental Contributions to Schizophrenia Pathoetiology
The genetic picture of schizophrenia remains unclear, however, the disorder runs strongly
in families: heritability is estimated to be between 60-80% based on family and twin
studies (Giusti-Rodriguez & Sullivan, 2013). However, schizophrenia does not exhibit
simple Mendelian inheritance and has a  strongly polygenic character.  Allelic variants
associated  with  schizophrenia  vary  from  rare  to  common  (Iyegbe  et  al.,  2014).
Inheritance of schizophrenia is also affected by copy number variations (CNVs), which
are structural variations in the genome consisting of microinsertions, microdeletions, and
transpositions;  these  mutations  are  more  frequent  than  base  pair  substitutions  and
multiple rare CNVs may contribute significantly to schizophrenia risk (Gershon et al.,
2011). Genome wide association studies (GWA studies, or GWAS) are large scale non
candidate driven studies of pooled DNA samples; these look for an association between
particular genetic loci and a set of phenotypes. Schizophrenia does not rely on a single
common genetic variant, and even taking the polygenic character of schizophrenia into
consideration, not all phenotypic variation is sufficiently explained by these studies (Lee
et al., 2012).
Cathecol-o-methyltransferase  (COMT)  is  a  well  studied  candidate  gene  for
schizophrenia  that  catalyzes  the  degradation  of  catecholamines,  and  is  the  primary
method  of  dopamine  degradation  (Schacht,  2016).  Two  isoforms  of  COMT  exist:  a
soluble isoform and a membrane bound isoform with 50 additional hydrophobic residues;
this membrane bound isoform is the primary form of COMT in neural tissue and has a
higher affinity for dopamine than the soluble isoform (Williams et al.,  2007). COMT
plays a role in managing executive function, attention, processing speed, and working
memory amongst other domains (Zai et al.,  2017). A single nucleotide polymorphism
2
(SNP), referred to as rs4680 or Val108/158Met (hereafter referred to as Val158Met), can
change the catalytic behavior of COMT dramatically; the valine variant leads to a 40%
increase in function due to the replacement of a methionine residue with a hydrophobic
residue, leading to greater protein stability (Williams et al., 2007). The mutation is likely
to influence the presentation and symptomology of schizophrenia; schizophrenic patients
with the  Val/Val  genotype show greater  incidence of  positive symptoms (Goghari  &
Sponheim, 2008) and altered temperament in the symptomatic phase (Hori et al., 2014).
Research  is  unclear  as  to  whether  or  not  this  mutation  confers  specific  risk  for
schizophrenia (Zai et al., 2017). 
Despite high heritability estimates of schizophrenia, the environment is posited to
be a non trivial factor in the development of the disease. Risk factors for schizophrenia
include migrant status, urban birth, cannabis use, childhood trauma and adversity, season
of birth, and obstetric complications (Iyegbe et al., 2014). Research on the potentially
synergistic effects of environmental influences and causative alleles on the development
of  schizophrenia  is  ongoing.  Gene  x  Environment  (GxE)  research  asserts  that  the
presence  of  disease  promoting  alleles  is  necessary  for  the  environment  to  assert  its
effects. Such research has shown that the 158Met COMT allele in the presence of stress
is  associated  with  psychotic  outcomes,  and  mutations  in  four  different  genes  in  the
presence of obstetric complications are associated with schizophrenia (Modinos et al.,
2013).
1.2 Oxygen homeostasis and hypoxia
Oxygen homeostasis is essential for the health and normal function of a cell, and the cell
works to maintain normoxia, an acceptable concentration of oxygen. Excess oxygen in
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the cell results in the presence of reactive oxygen species that are capable of damaging
essential  cellular  components  (Semenza,  2007).  When  oxygen  levels  drop  below  an
acceptable level, the cell responds with a finely tuned cascade of signaling to transition to
anaerobic  respiration,  increase  vascularization  in  order  to  increase  blood  flow to  the
affected tissue, and mitigate any damage that may occur within the cell and the tissue as a
whole (Semenza, 2007). 
The primary mediator of the hypoxic response is hypoxia inducible factor 1 (HIF-
1), a heterodimeric transcription factor consisting of HIF-1α and HIF-1β (Déry et  al.,
2005). HIF-1β is also known as aryl hydrocarbon nuclear receptor translocator (ARNT);
in  addition  to  being  part  of  the  HIF-1  heterodimer,  it  is  a  binding  partner  of  aryl
hydrocarbon receptor (AhR) (Mandl & Depping, 2014). Both proteins are constitutively
expressed  by  the  cell,  and  HIF-1  activity  is  primarily  regulated  post-translationally
(summarized  in  Figure  1.1).  Under  normoxic  conditions,  HIF1-α  is  hydroxylyzed  by
prolyl  hydroxylase  2  (PHD2)  in  an  oxygen  dependent  manner,  targeting  it  for
ubiquitylation  by  the  pVHL  (von  Hippel  Lindau  protein)  complex,  targeting  it  for
digestion  by  the  proteasome (Déry  et  al.,  2005;  Ke & Costa,  2006).  Under  hypoxic
conditions, HIF-1α is not targeted for protein digestion due to a lack of PHD2 activity,
allowing HIF-1α to freely bind HIF-1β, creating the HIF-1 transcription factor that can be
translocated into the nucleus and mediate the appropriate transcriptional response (Ke &
Costa, 2006). 
1.2.1 Transcriptional Activity Under Hypoxia
The HIF-1 transcription factor binds directly to the hypoxia response element (HRE), a
short  nucleotide  sequence  present  in  the  promoters  of  hundreds  of  genes  (Correia  &
Moreira, 2010; Ramakrishnan et al., 2014). The majority of pathways induced by this 
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5Figure 1.1. Post translational regulation of HIF-1α by hydroxylation and ubiquitylation.
Under normoxia, sufficient oxygen is available to the cell and PHD2 hydroxylates key
residues on the mature HIF-1α protein in an O2 dependent manner. This allows the Von
Hippel Lindau complex to bind HIF-1α and ubiquitinate it, marking it for degradation
by the proteasome. As PHD2 requires oxygen to react with HIF-1α, under low oxygen
conditions  HIF-1α is  not  hydroxylated  and therefore cannot  be ubiquitylated by the
VHL complex, allowing HIF-1α to bind ARNT/HIF1-β, allowing movement into the
nucleus and the beginning of hypoxia related transcriptional activity. 
Figure  adapted  from  Ke,  Q.,  &  Costa,  M.  (2006).  Hypoxia-Inducible  Factor-1  (HIF-1).  Molecular
Pharmacology, 70(5), 1469–1480. https://doi.org/10.1124/mol.106.027029
transcriptional activity relates to increasing the oxygen supply and repairing tissue after
hypoxic  injury  and  inflammation.  HIF-1  stimulates  the  expression  of  nitric  oxide
synthases  (NOSs)  to  induce  vasodilation  and  increase  blood  flow  to  the  tissue
(Ramakrishnan et al., 2014). Glycolysis, gluconeogenesis, and glucose transport activity
transcriptional activity are also modified due to the necessity of shifting to anaerobic
respiration during hypoxic events (Ratcliffe et al., 1998).  HIF-1 is a major regulator of
angiogenic  activity  due  to  its  stimulation  of  angiogenic  growth  factors;  other  genes
regulating angiogenesis have HREs in their promoters (Pugh & Ratcliffe, 2003). 
HIF-1 is directly responsible for increasing expression of erythropoietin and its
receptor (EPO and EPOR) and vascular endothelial growth factor (VEGF) (Ke & Costa,
2006). VEGF signaling induces angiogenesis, the process of creating new blood vessels
from  existing  blood  vessels.  Also  known  as  VEGFA,  VEGF  is  a  homodimeric
glycoprotein  with  various  isoforms  that  have  different  biological  activity;  it  is  the
prototype member of the VEGF family of proteins (Ferrara et al., 2003). Three major
isoforms of VEGF exist:  VEGFA-121, VEGFA-165 and VEGFA-189, named for the
number  of  amino  acids  in  each  isoform  (Rosenstein  et  al.,  2010).  VEGFA-121  is
diffusible, while VEGFA-189 associates with the extracellular matrix (Arcondéguy et al.,
2013);  VEGFA-165 is  a  hybrid  that  can  be  secreted  but  can  still  associate  with  the
extracellular  matrix  (ECM)  and  cell  membrane  (Ferrara  et  al.,  2003).  The  isoforms
VEGFA-121  and  VEGFA-165  bind  to  the  receptors  VEGFR-1  (vascular  endothelial
growth  factor  receptor)  and  -2  (Woolard  et  al.,  2009);  VEGFA-165,  and  possibly
VEGFA-189, can also bind to neuropilin (NRP) 1 and 2 (Rosenstein et al., 2010). The
activation of VEGFR-2 results in a prosurvival, mitogenic, and angiogenic signal (Ferrara
et  al.,  2003);  while  the  binding  of  VEGFA-165  to  NRP1 enhances  the  signaling  of
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VEGFR-2 (Plein, Fantin, & Ruhrberg, 2014). Of the three major isoforms, VEGFA-165
is the predominant regulator of angiogenesis and is a potent angiogenic factor (Woolard
et al., 2009).
1.2.2 Hypoxia and the Nervous System
As the brain requires a significant amount of oxygen, hypoxic conditions can be severely
damaging to neural tissues. Without a robust hypoxic response, neurons reach cell death
due  to  overactivation  of  NMDA  receptors  (Corcoran  &  O’Connor  2014).  During
hypoxia, adenosine levels significantly increase in the neuron, leading to an inhibition of
signaling in neural tissue during an ischemic event (Mukandala et al., 2016). Studies of
cerebral  ischemic  stroke  have  shown  HIF-1  and  its  transcriptional  targets  to  have
neuroprotective effects. Inducing EPO expression is a crucial step in protecting against
ischemic  injury;  in  addition,  VEGF itself  may  have  a  directly  neuroprotective  effect
during such events (Correia & Moreira, 2010). VEGF has homeostatic functions in the
brain  beyond managing vascularization;  it  acts  as  a  factor  in  adult  neurogenesis  and
contributes to synaptic plasticity, enhancing memory in a manner not solely due to its
angiogenic functions (Licht & Keshet, 2013). 
However, HIF-1 has a dual nature: it directly regulates p53 and other cell cycle
control genes in response to a lack of oxygen and glucose, leading to the activation of
apoptotic pathways during ischemic stroke (Singh et al., 2012). Changes in PHD2, the
primary  mediator  of  HIF-1α  digestion,  also  lead  to  increased  neuronal  cell  death
(Corcoran & O’Connor, 2014). With regards to schizophrenia, candidate genes identified
in GWA studies are regulated by the hypoxic response (Schmidt-Kasner et al., 2012). 
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1.3 Viruses
Viral  infections  have  been  theorized  to  play  a  role  in  the  etiopathogenesis  of
schizophrenia  and  other  neuropsychiatric  issues;  for  example,  Rubella  and  herpes
simplex  virus  infections  may  contribute  to  a  number  of  neuropsychiatric  problems
(Brown, 2011). Proposed mechanisms by which infection can contribute to neurological
and psychiatric  irregularities  in  the  neurodevelopmental  model  include  disrupting  the
laterality  of  brain  development  and  provoking  an  immune  response  (Pearce,  2001).
Infectious  agents shown to be associated with schizophrenia in meta analysis  include
human herpesvirus,  borna disease virus,  endogenous retroviruses,  Toxoplasma gondii,
Chlamydophila pneumoniae and Chlamydophila psittacci (Arias et al., 2012). 
Human  endogenous  retroviruses  (HERVs),  the  result  of  ancient  retroviral
infections in which viral DNA have been fixed in the germline and inherited through
generations in a Mendelian fashion, are ubiquitous and make up to 8% of the human
genome (Christensen, 2016). Exogenous retroviruses and endogenous retroviruses share a
similar structure, comprising a DNA sequence containing three a sequence of the genes
gag, env, and pol, flanked by long terminal repeats (LTRs); however, not all loci are
active in  a  given HERV due to  the accumulation  of  mutations  (Hansen,  Petersen,  &
Christensen, 2017). HERV sequences are highly heterogeneous and studying these viral
families can be difficult due to the number of mutations present (Slokar & Hasler, 2016).
HERVs are associated with some human malignancies, and multiple mechanisms
have been proposed as to how they may exert their effects. Possible methods include
interrupting the expression of other genes through enhancers and responsive elements
present in HERV sequences; the transcription and translation of HERV gene products for
HERVs that have functional open reading frames; and hypothetically, new movements of
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HERV sequences could disrupt and knock out existing genes (Christensen, 2010). The
HERV-H/F and HERV-W families are associated with multiple sclerosis (MS) risk and
disease course (Christensen, 2016). Elevated levels of HERV-W family transcripts have
been detected in schizophrenic patients while in remission, suggesting that the expression
of HERV-W transcripts is constitutive in these patients rather than associated with an
acute  phase  of  the  disease  (Perron  et  al.,  2012),  and  multiple  studies  support  the
conclusion of an association between HERV-W and schizophrenia (Arias et al., 2011).
Another family, HERV-K(HML-2), is highly polymorphic; HERV-K113 is the likely the
youngest  HERV  fixed  in  the  genome  and  is  present  in  ~16%  of  the  population
(Subramanian et al., 2011). In addition, HERV-K113 is capable of producing intact viral
particles (Boller et al., 2008). This family of viruses is also associated with schizophrenia
and bipolar disorder (Christensen, 2010; Slokar & Hasler,  2016), but has not been as
thoroughly studied as the HERV-W family in mental illness. 
1.4 Purpose
Schizophrenia  research  has  established  that  it  is  a  disease  with  a  high  degree  of
heritability.  GWA studies  have  identified  candidate  genes  that  possibly  contribute  to
schizophrenia  pathology.  Epidemiological  studies  have  identified  numerous
environmental  risk  factors  for  schizophrenia,  G  x  E  research  has  demonstrated
connections between risk alleles and environmental factors, and clinical and molecular
studies  have  demonstrated  links  between viruses  and neurological  abnormalities.  The
field of schizophrenia research is embracing bioinformatics by harnessing the power of
genomics  and searching for alleles  that  confer  risk,  clarifying the complex polygenic
character  of  schizophrenia,  and  examining  the  relationship  between  environmental
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influences and these risk alleles. Studying the schizophrenia transcriptome, the sum total
of RNA molecules present in the tissues of schizophrenic patients, is a field still in its
infancy despite the progress made using genomic approaches. 
The data presented here is a preliminary study of the use of RNA sequencing data
in  examining  the  relationship  between  environmental  variables  and  schizophrenia
pathoetiology  through  differential  gene  expression  data,  and  an  examination  of
alternative splicing events in schizophrenia. Additionally, this paper analyzes the use of
bioinformatic tools to probe for the presence of viruses in schizophrenia to evaluate the
viral hypotheses surrounding neurological irregularities. 
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CHAPTER 2
METHODS
Several tools used for analyzing next generation sequencing output were used to evaluate
relevant  changes  in genetic  expression,  alternative splicing,  and the presence of  viral
transcripts. These studies all used RNA sequencing (RNAseq) data. RNAseq is a next
generation sequencing (NGS) technique where RNA is isolated from a cell (ribosomal
RNA  is  removed)  and  converted  to  cDNA  (complementary  DNA)  which  is  then
converted into a library for sequencing (Kukurba & Mongtogmery, 2015). This outputs
sequenced “reads”, short sequences generally 50-200bp (base pairs) long, which are then
aligned to a genome of interest to examine the transcriptome of the sequenced tissue.
2.1 Tools and Annotation Used Throughout the Study
Programs used throughout the study are listed in Table 2.1 along with the versions used
for  all  experiments  listed.  For  all  alignments,  the  UCSC  GRCh37/hg19  assembly
available  from  the  UCSC  website  was  used.  The  ready  to  use  reference  sequence
annotations from Illumina iGenome, procured through the Tuxedo protocol website as a
GTF file,  were  used  as  annotation  for  differential  gene  expression  experiments.  For
isoform analysis using MISO isoform centric annotations based on Ensembl identifiers
were procured from the MISO documentation website. 
2.2 RNAseq and Preprocessing
Amygdala  samples  collected post-mortem from a schizophrenic patient  and a  control
patient  were  sequenced  using  Illumina  MiSeq  technology.  Trim Galore!  was  used to
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remove Illumina sequencing adapters and eliminate low quality reads and bases. FastQC
was run before and after Trim Galore! and indicated no significant issues with the reads
after processing with Trim Galore!. This protocol also produces single end reads from
paired  end  reads  with  one  low  quality  end,  however,  these  were  not  used  in  any
downstream analysis. Table 2.2 shows information on each set of reads. These cleaned
reads were used in all experiments that follow. 
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Table 2.1 Recurring Software Used in Analysis
Software Version
Tophat 2.1.0
Bowtie 2 2.2.6
Samtools 1.2
R 3.3.0
CummeRbund 2.14.0
goseq 1.24.0
Cuffdiff 2.2.1
Python 2.6
Table 2.2 RNAseq Read Information
Sample
Read 
Identifier
Reads 
Preprocessing
Reads 
Postprocessing
Control CONTROL 59516254 58138821
Schizophrenic
SCZ1 40856069 39761883
SCZ2 40914245 39808368
2.3 Differential Gene Expression Analysis
The Tuxedo protocol described by Trapnell, et al. (2012) was used to align and generate
differential expression results. Tophat uses Bowtie 2 as its alignment engine. Bowtie 2 is
a general purpose aligner that proceeds in two steps: it first uses a full-text minute index
to find seeds, then uses dynamic programming to produce gapped alignments from these
seeds (Langmead & Salzberg, 2012). Tophat splits reads that Bowtie 2 cannot align into
segments; often these segments can align to different sites in the genome. Tophat infers
that  these  reads  align  to  splice  sites,  and is  also capable  of  discovering novel  splice
junctions.
Cufflinks is used in the transcript assembly step, taking reads aligned by Tophat
as input and quantifying the expression level of each transfrag. The utility Cuffmerge
creates a full transcriptome assembly by combing the assemblies of multiple sames and
combining them parsimoniously with a reference assembly. This new assembly is then
fed into Cuffdiff where differential expression of genes is calculated. This data is finally
analyzed  using  CummeRbund,  an  R  package  designed  to  specifically  analyze  data
generated by the Tuxedo protocol. 
2.4 Isoform Analysis
MISO (Mixture of Isoforms) uses a probabilistic framework to analyze isoforms based on
RNAseq data  (Katz et  al.,  2010).  Reads that  align to an event  are assigned as either
consistent  or  inconsistent  with  a  given transcript.  This  is  reported  in  terms of  Ψ,  or
“percentage spliced in”. The probability of Ψ, given multiple reads, is proportional to the
likelihood of a read arising from an isoform given Ψ and the prior probability of Ψ, which
is uniform. The mean of this distribution is used as an estimate for Ψ. MISO calculates
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the probability distribution of ΔΨ for both the null hypothesis ΔΨ = 0 and the alternative
hypothesis ΔΨ ≠ 0. The measure of significance returned, the Bayes factor, is a ratio of
the probability of the alternative hypothesis to the null hypothesis. 
As the utilities to probe miso_compare output provided by the MISO team were
designed to work with exon centric analysis rather than isoform centric analyses, events
of interest were probed manually with Perl and Python scripts. MISO events with at least
one isoform having a Bayes factor greater than or equal to 20, a posterior mean difference
(ΔΨ) of at least 0.2, and the sum of 200 reads identified as belonging to an event were
filtered  as  significant.  470 such  events  were  detected.  These  other  significant  events
include changes in isoforms of genes involved in neural signaling pathways, and as such
they  are  beyond  the  scope  of  this  document  and  were  not  explored  further.  The
sashimi_plot utility provided by the MISO team was used to generate plots for events of
interest with default settings, except for changes in the y-axis to visualize events more
clearly. 
2.5 Gene Ontology Term Analysis
To  develop  a  richer  picture  of  what  transcriptional  pathways  were  enriched,  gene
ontology analysis using the GOseq algorithm was performed. Gene ontology (GO) terms
were  created  to  provide  a  vocabulary  to  describe  different  biological,  cellular,  and
molecular  processes  within  a  tissue  of  interest  (Ashburner  et  al.,  2000).  The  GOseq
algorithm  uses  a  binary  operator  on  each  gene  to  indicate  whether  or  not  it  was
differentially expressed. This information is fit into a probability weighting function to
establish a null hypothesis; random resampling of genes establishes what GO categories
are  underrepresented  or  overrepresented  (Young  et  al.,  2010).  This  analysis  was
14
performed  using  the  implementation  in  the  goseq R  package,  available  through
Bioconductor.
Genetic events identified as having significant changes in expression by Cuffdiff
were used as input for goseq to evaluate changes in gene expression; this analysis used
gene  symbols  as  identifiers.  To  detect  if  there  were  significant  changes  in  isoform
abundance in a given process, MISO data was also analyzed using  goseq. Genes were
marked as differentially expressed if any isoform in a gene had a Bayes factor >10 and
posterior  mean difference >0.1.  Ensembl gene identifiers  were used for  this  analysis.
Events were considered significant with p<0.01. GO terms regarding basic neurological
functions were not considered in further analysis as this work focuses on environmental
factors that may contribute to schizophrenia pathoetiology. 
2.6 Virus Detection
The VERSE approach described by Wang, Jia,  and Zhao (2015),  implemented in the
open source software package VirusFinder 2, was used to detect the presence of viral
transcripts in both samples. VERSE, an abbreviation for Virus intEgration sites through
iterative  Reference  SEquence  customization,  is  a  protocol  designed  to  detect  viral
transcripts  and integration  sites.  The approach of  VERSE differs  from previous  viral
detection  by  accounting  for  virus  evolution  and  the  mutations  that  accompany  this
process; by making iterative changes in viral genomes and host genomes more integration
events can be detected and mutations in viral sequences can be detected.
VirusFinder  2  uses  Bowtie  2  to  align  paired-end  reads  to  the  genome.
Discordantly  aligned  paired  end  reads,  reads  that  are  soft-clipped  (having  partial
alignments to the target genome), and unaligned reads are considered to be of possible
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viral origin. These candidate viral genes are aligned against a user-defined set of viral
genomes using BWA. The tool ICORN is iteratively used to identify SNPs and indels and
modify the viral reference genomes as necessary; sites that have high likelihood of viral
integration events are also modified using ICORN. Transcript assembly is then performed
by Trinity; blastn is used to align these sequences back onto human and viral genomes,
leading to the detection of viruses present in the sample.
The  RNAseq  reads  described  in  Table  2.2  (not  the  alignments  produced  by
Tophat used in differential expression analysis and isoform analysis) were used as input
for VirusFinder 2. 11,981 genomes of viruses capable of infecting humans were collected
from NCBI Genbank and EMBL-EBI European Nucleotide Archive.  These sequences
were concatenated into a “viral chromosome” for virus detection. VirusFinder2 and the
VERSE algorithm can also be used to detect viral integration sites along with SNPs and
indels in viral sequences. Unfortunately, due to issues with a dependency of VirusFinder2
required for the integration analysis (SVDetect), this analysis was not performed. As viral
mutation analysis follows from this step, virus mutations were also unable to be detected. 
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CHAPTER 3
RESULTS
3.1 HIF-1 Expression
Expression of HIF-1α was found to be enriched in the schizophrenic patient (log2  fold
change=0.456, p=0.0128). As discussed in Section 1.3, the HIF-1 heterodimer consisting
of  HIF-1α and HIF-1β/ARNT mediates  the  the  hypoxic  response;  in  addition,  HIF-1
activates growth factors that stimulate transcriptional activity of HIF-1α itself (Ke and
Costa  2006).  Cuffdiff  did  not  detect  a  significant  change  in  the  expression  of  HIF-
1β/ARNT (p=0.240). However, MISO detected significant differences in the transcript
abundance of HIF-1β/ARNT. 
3.1.1 ARNT Transcript Analysis
Two different transcripts for ARNT were detected in both samples (Table 3.1, Figure
3.1).  ARNT  has  four  different  protein  isoforms  (Uniprot  Consortium  2017).  The
canonical sequence, known as “Long”, was the only significant protein coding transcript
detected in either sample. This transcript form was more prevalent in the schizophrenic
patient (Bayes factor 40.3). A second transcript, theorized to undergo nonsense mediated
decay, was more prevalent in the control patient (Bayes factor 55.88). Because the decay
transcript is based on automatic annotation of the human genome by the Ensembl project
and has not been detected experimentally, this result is equivocal. However, this evidence
does  suggest  that  there  was  a  greater  quantity  of  functional  ARNT  mRNA  in  the
schizophrenic patient. 
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3.1.2 HIF-1 Repressor Expression
HIF-1α is primarily degraded by a complex containing pVHL following hydroxylation by
PHD2  (Liu,  et  al.,  2012).  EGLN1,  the  coding  gene  for  PHD2,  did  not  show  any
significant changes in expression, nor did VHL (Table 3.2). Multiple transcripts exist for
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Figure 3.1 Sashimi plot of MISO data for reads falling in the ARNT region of the human
genome. Lines  between  read  densities  represent  reads  spanning  exon-exon  junctions;
greater line weight indicates a greater number of supporting reads. Read density given in
reads per kilobase million (RPKM). a) Density of reads falling in the ARNT region of the
genome in the control patient. b) Density of reads falling in the ARNT region of the
schizophrenic patient. c) Cartoon diagram of exon-intron structure for relevant isoforms
of ARNT derived from the Ensembl annotation. Top, ARNT-1 (long); bottom, nonsense
mediated decay. 
Table 3.1 Assigned Transcript Counts of ARNT
Isoform
Assigned Transcript Counts
Posterior mean Bayes factor
Control Schizophrenic
ARNT-1 (long) 118 215 -0.43 40.3
Decay 148 21 0.44 55.88
* Only isoforms with ≥25 assigned transcripts shown.
** Decay refers to the theorized ARNT transcript that undergoes nonsense mediated decay. 
PHD2, EGLN1, and PHD2; however, MISO did not detect any changes in the splicing of
these genes. There were significant changes in the expression of CUL2 (cullin-2) and
TCEB1 (elongin-C), while RBX1 (ring-box 1) showed no change in expression (Table
3.2). The presence of all components of the ubiquitylation complex and PHD2 in the
schizophrenic patient indicate that activation of HIF-1 was likely not due to deficiencies
in its degradation. 
3.2 Transcriptional Effects of the Hypoxic Response
3.2.1 VEGFA Transcript Analysis
Expression of VEGFA, a primary target of HIF-1 transcriptional activity, was elevated in
the  schizophrenic  patient  (log2 fold  change=1.36972,  p<0.001).  MISO  detected
significant  increase  in  L-VEGFA-165  transcripts  in  the  schizophrenic  patient  (Bayes
factor  264.44);  changes  in  the  abundance  of  L-VEGFA-121  and  VEGFA-121  were
insignificant (Table 3.3). No VEGFA-189 transcripts were detected at significant levels
in either patient. L-VEGFA-XXX transcripts are transcribed from an alternate CUG start
codon and include a highly conserved region that is cleaved post-translationally; this 
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Table 3.2 HIF-1 Degradation Pathway Expression
Gene log2 fold change p q
VHL 0.23349 0.0787 0.172
EGLN1 0.134845 0.323 0.468
TCEB1 0.439748 0.00185 0.00951
CUL2 -0.426474 0.0029 0.0137
RBX1 0.0974297 0.471 0.612
* Positive log2 fold change indicates  more expression in the schizophrenic patient.  Rows shaded gray
indicate significant changes in expression.
cleavage produces a protein identical to the canonical isoform (Huez et al., 2001). As
discussed in 1.2, both isoforms of VEGF detected have similar properties and are capable
of activating VEGF receptors. VEGFA-121 is secreted while VEGFA-165 can either be
secreted or associated with the ECM; of the two, VEGFA-165 is the more active and is
also able to bind to NRP1 to enhance VEGFR-2 signaling. 
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Figure 3.2  Sashimi plot of MISO data for reads falling in the VEGFA region of the
human  genome. Lines  between  read  densities  represent  reads  spanning  exon-exon
junctions;  greater  line  weight  indicates  a  greater  number  of  supporting  reads.  Read
density given in reads per kilobase million (RPKM). a) Density of reads falling in the
VEGFA region of the genome in the control patient. b) Density of reads falling in the
VEGFA region of the schizophrenic patient. c) Cartoon diagram of exon-intron structure
for  relevant  isoforms of  VEGFA derived from the  Ensembl  annotation.  From top to
bottom: L-VEGFA-165, L-VEGFA-121, VEGFA-121. 
Table 3.3 Assigned Transcript Counts of VEGFA
Isoform
Assigned Transcript Counts
Posterior mean Bayes factor
Control Schizophrenic
L-VEGFA-165 64 478 -0.31 264.44
VEGF-121 148 200 0.07 0.67
L-VEGFA-121 66 44 0.21 0.63
* Only isoforms with ≥ 25 assigned transcripts shown.
3.2.2 Gene Ontology Enrichment of HIF-1 Targets
HIF-1 activates genes involved in erythropoiesis, angiogenesis, glucose metabolism, and 
apoptosis (Ke & Costa, 2006). Analysis of genes with significant differences in 
expression as detected by the Cufflinks workflow showed activation of pathways relating
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Table 3.4 Overrepresented GO Terms Regarding Hypoxia From Cufflinks Data
Gene Ontology Term p Description
Angiogenesis
GO:0002040 0.00138 Sprouting angiogenesis
GO:0001525 <0.001 Angiogenesis
Erythropoesis
GO:0045648 <0.001 Positive regulation of erythrocyte differentiation
GO:0045646 0.00561 Regulation of erythrocyte differetiation
GO:0034101 0.00252 Erythrocyte homeostasis
GO:0030218 0.00243 Erythrocyte differentiation
Apoptosis
GO:0097190 0.00740 Apoptotic signaling pathway
GO:2000425 0.00921 Regulation of apoptotic cell clearance
Table 3.5 Overrepresented GO Terms Regarding Hypoxia From MISO Data
Gene Ontology Term p Description
Glucose metabolism
GO:0006007 0.00184 Glucose catabolic process
GO:0090649 0.00545 Response to oxygen-glucose deprivation
GO:0090650 0.00545 Cellular response to oxygen-glucose deprivation
GO:0006006 0.00926 Glucose metabolic process
to angiogenesis, erythropoiesis, and apoptosis (Table 3.4). While changes in glucose 
metabolism are a cardinal sign of a hypoxic response, no significant changes in glucose 
metabolism pathways were detected by goseq in the Cufflinks data. Although terms 
relating to glucose metabolism were missing in the gene ontology analysis of expression 
data, gene ontology analysis of alternative splicing (using a Bayes factor of 10 as a 
threshold for significance) revealed changes in transcript abundance in terms relating to 
glucose metabolism (Table 3.5). There were no terms shared in common by both datasets.
3.3 HIF-1 and Regulation of Schizophrenia Candidate Genes
Expression data for fourteen candidate genes for schizophrenia relating to hypoxia were
examined  to  investigate  the  possibility  of  the  hypoxic  transcriptional  response
contributing  to  schizophrenia  pathoetiology.  Nine  genes  had  significant  changes  in
expression between the two patients (two genes were untested by Cufflinks). While the
majority  of  genes  showed  concordance  with  their  expected  change  in  response  to
hypoxia, several genes had expression profiles that did not follow this pattern (Table 3.6).
3.3.1 COMT Transcript Analysis
COMT expression was elevated in the schizophrenic patient and transcript abundance
was altered between the two samples. COMT has two well characterized isoforms, one
membrane bound and one soluble. Transcripts for the soluble isoform of COMT were not
detected in either patient; this is expected as the membrane bound isoform predominates
in brain tissue (Williams, Owen & O’Donovan, 2007). Multiple transcripts code for the
membrane-bound isoform, referred  to  as  variants  1,  2,  and 3.  These  three transcripts
differ  in  the  5’  UTR  and  may  affect  translation  (the  Ensembl  annotation  used  for
alternative splicing analysis does not differentiate between variants 1 and 2), however the
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significance  of  these  transcripts  is  unclear.  A  truncated  223aa  transcript  of  COMT,
missing the 48 C-terminal  residues  present  in  both the soluble and membrane bound
isoforms, was detected in the schizophrenic patient (Table 3.7).  This transcript is  not
confirmed and only supported by limited protein data (Uniprot Consortium 2017). This
truncated transcript does not include a key residue involved in substrate binding and once
translated, may not be catalytically active. Additionally, by extracting reads mapped to
the COMT region of the genome, the control patient was determined to be homozygous
for COMT Val158, while the schizophrenic patient was homozygous for the less active
Met158. 
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Table 3.6 Expression of Hypoxia/Ischemia Regulated Candidate Genes
Gene log2 fold change p q
AKT1 0.0122 0.931 0.957
CNR1 -1.09 <0.001 <0.001
COMT 0.478 0.0059 0.0241
DTNBP1 0.724 <0.001 <0.001
GAD1 -1.012 <0.001 <0.001
GRM3 -0.793 <0.001 <0.001
IL10 Not tested
MLC1 0.185 0.153 0.276
NOTCH4 0.507 0.0125 0.0434
NR4A2 0.988 <0.001 <0.001
NRG1 -2.412 <0.001 <0.001
RELN -0.192 0.212 0.348
RGS4 -1.975 <0.001 <0.001
TNF Not tested
* Positive log2 fold change indicates  more expression in the schizophrenic patient.  Rows shaded gray
indicate significant changes in expression. 
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Figure 3.3 Sashimi plot of MISO data for reads falling in the COMT region of the human
genome. Lines between read densities represent reads spanning exon-exon junctions; 
greater line weight indicates a greater number of supporting reads. Read density given in 
reads per kilobase million (RPKM). a) Density of reads falling in the COMT region of 
the genome in the control patient. b) Density of reads falling in the COMT region of the 
schizophrenic patient. c) Cartoon diagram of exon-intron structure for relevant isoforms 
of COMT derived from the Ensembl annotation. From top to bottom, MB-COMT 
variants 1 & 2, trunctated, MB-COMT variant 3. 
Table 3.7 Assigned Transcript Counts of COMT
Isoform
Assigned Transcript Counts
Posterior mean Bayes factor
Control Schizophrenic
MB-COMT 
variant 1 and 2
194 316 -0.01 0.05
MB-COMT
variant 3
541 489 0.27 136.04
Truncated 36 305 -0.32 28872.58
* Only isoforms with ≥ 25 assigned transcripts shown.
** Truncated refers to the unconfirmed COMT transcript missing key C-terminal residues required for 
enzymatic activity. 
3.4 Presence of Active Viral Transcripts
VirusFinder2  was  used  to  detect  the  presence  of  viruses  in  both  samples  (Chapter
2.section).  An endogenous retrovirus (HERV-K113) was detected in one set  of reads
(SCZ2, see Section 2.2 and Table 2.2) in the schizophrenic patient (Table 3.8). Viral
integration data was not obtained due to issues with a dependency of VirusFinder2. No
sequence similarity between the HERV-K113 genome and the human genome and human
transcripts were detected by blastn analysis (data not shown), making it unlikely that this
is a false positive. 
A modified Vaccinia virus, Vaccinia GLV-1h68, used as an oncolytic vector in
experimental cancer treatment (Pugalenghthi et al., 2015) was detected in both samples.
However,  the  GLV-1h68  genome has  high  identity  with  the  gene  TFRC (transferrin
receptor); in addition, both sequences are highly repetitive (data not shown). Expression
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Table 3.8 VirusFinder Results of Note in Schizophrenic Patient
Virus name Identities (%) Reads on contigs
ENA|EU410304|EU410304.1
Vaccinia virus GLV-1h68, complete genome.
100 69
gi|548558394|ref|NC_022518.1
Human endogenous retrovirus K113 complete 
genome
95.61 16
Table 3.9 Overrepresented GO Terms Regarding Viral Response From Cufflinks
Gene Ontology Term p Description
GO:0009615 <0.001 Response to virus
GO:0051607 <0.001 Defense response to virus
GO:0050688 0.00272 Regulation of defense response to virus
GO:0098586 0.00426 Cellular response to virus
of  TFRC was  detected  in  both  samples  by  Cufflinks.  Vaccinia  GLV-1h68  has  high
sequence similarity with other Vaccinia genomes; however no other Vaccinia genomes
were detected by VirusFinder2. Taken together, the Vaccinia GLV-1h68 hit is likely a
false  positive.  Viral  integration analysis  would  confirm whether  or  not  this  sequence
detected by VirusFinder2 is from the TFRC region of the genome. 
Gene ontology enrichment analysis by goseq of the Cufflinks data also revealed
enrichment of terms relating to the viral immune response (Table 3.9); analysis of the
MISO data did not reveal any significant enrichment of these terms. The detection of
viral transcripts in the schizophrenic patient, in addition to changes in expression of genes
relating to the cellular virus response, present a strong case that active viral transcripts,
and possibly proteins, were present in the schizophrenic patient. 
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CHAPTER 4
DISCUSSION
This analysis should be considered as an exploratory study rather than demonstrating any
definitive connections between hypoxia,  viruses, and schizophrenia;  these results  only
represents details from one schizophrenic patient and one control patient. However, this
document presents several tantalizing directions for research to follow with regards to the
pathoetiology of schizophrenia, using an approach not yet fully explored by the literature.
4.1 Hypoxic Response
A  hypoxic  response  was  occuring  in  the  amygdala  of  the  schizophrenic  patient  as
indicated  by  RNAseq  analysis,  demonstrating  that  HIF-1alpha  transcription  was
enhanced  and  transcription  of  downstream  targets  of  HIF-1,  including  VEGF,  was
enriched. Additional analysis demonstrates that this reaction is not due to any obvious
deficiencies in the expression of proteins involved in the post-translational regulation of
HIF-1alpha.  There exists  a possibility that this  transcriptional activity associated with
hypoxia is due to a genuine lack of oxygen in the cell. Given the current knowledge of
schizophrenia  pathoetiology,  and  theories  regarding  genes  regulated  by  hypoxia
contributing to schizophrenia, it  is possible that this transcriptional activity associated
with hypoxia contributed to symptoms in this patient.
VEGFA  expression  was  increased  in  the  schizophrenic  patient,  along  with  a
significant change in transcript abundance, indicating a change in the active isoforms of
VEGFA.  Changes  in  splicing  of  VEGFA pre-mRNA is  a  possible  method  of  finely
regulating angiogenesis and significantly more L-VEGFA-165 transcripts were detected
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in  the  schizophrenic  patient.  Although  there  are  several  isoforms  of  VEGFA,  only
transcripts  correlating to the VEGFA-121 and VEGFA-165 isoforms were detected at
significant levels. The major transcript in the control patient, and a significant portion of
the transcripts present in the schizophrenic patient, were VEGFA-121; this contradicts
research in animal models that the primary isoform in the brain is VEGFA-165 (Vempati,
Popel, & Mac Gabhann, 2014) and that only low levels of VEGFA-121 are present in the
brain  (Woolard  et  al.,  2009).  The  majority  of  VEGFA  transcripts  detected  in  both
samples were long isoforms, which are post-translationally cleaved; once this occurs, the
long isoforms are functionally the same as the canonical isoforms (Huez et al., 2011).
Changes in the expression of the long isoforms of VEGFA are associated with a number
of  detrimental  effects,  including  greater  risk  of  motor  neuron  degeneration  in
amyotrophic lateral sclerosis (Arcondéguy, et al., 2013). 
Beyond the three primary isoforms of VEGF (VEGFA-121, VEGFA-165, and
VEGFA-189), other isoforms of VEGF have been discovered with differing properties.
The VEGFA-xxxb class of isoforms has only weakly angiogenic properties (Catena et al.,
2010). However, VEGFA-xxxb transcripts have only been detected using RT-PCR data;
analysis  of  publicly  available  NGS  (next  generation  sequencing)  datasets  of  tissues
reported  to  have  high  expression of  these  isoforms did  not  detect  any VEGFA-xxxb
transcripts (Bridgett et al., 2017). Additionally, an isoform of VEGF with a unique 22
amino acid extension at the C-terminal, VEGFA-Ax, is produced by post-translational
read through of the VEGFA mRNA (Eswarrapa et al., 2014); Initially this isoform was
reported to be anti-angiogenic, however later research suggests that VEGFA-Ax isoforms
are weakly angiogenic (Xin et al., 2016). As this modification is post-translational, it is
impossible to detect in RNAseq data, but its presence in either patient is a possibility. 
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4.2 Possible Contribution of Hypoxia to Schizophrenia
Candidate genes theorized to contribute to schizophrenia pathology that are directly or
indirectly  regulated  by  hypoxia-related  transcriptional  activity  showed  significant
differences in expression between the two samples. This strengthens the hypothesis that
the  hypoxic  response  occurring  in  the  schizophrenic  patient  contributed  to  their
symptoms. As shown in Table 3.6, multiple candidate genes for schizophrenia identified
through GWA studies affected by this signaling pathway did have significant differences
in expression, most of which was concordant with the expected changes in the expression
of these genes under a hypoxic/ischemic event. 
COMT is one of the most  well  studied genes contributing to neuropsychiatric
abnormalities. However, the overall picture of COMT activity as compared between the
two patients is cloudy due to the differing Val158Met genotypes. The control patient is
homozygous for the Val158 genotype, while the schizophrenic patient is homozygous for
158Met. The Val158 genotype of COMT results in an enzyme with 40% higher activity
than the 158Met variation; there is no compensatory expression of COMT in 158Met
homozygotes to account for this decreased activity (Chen et al., 2004), thereby overall
158Met  homozygotes  have  less  COMT activity  and  concomitantly,  higher  dopamine
levels.  Despite  the  increased  expression  of  COMT  in  the  schizophrenic  patient,
evaluating any differences in COMT activity between the two patients is difficult due to
the  presence  of  the  truncated  transcript  in  the  schizophrenic  patient,  the  different
Val158Met genotypes, and the unclear effects of differing 5’ UTRs in each transcript
variant detected by MISO.
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4.3 HERVs and Schizophrenia
Transcripts  of  HERV-K113  were  detected  in  the  schizophrenic  patient,  alongside
expression data indicating that an active viral response was occuring in the schizophrenic
patient  at  the  time  of  death;  no  other  viral  genomes  were  found that  would  suggest
another source of infection. As discussed in 1.3, HERV-K113 is capable of producing
intact  viral  particles  (Boller  et  al.,  2008)  and  has  a  single  ORF for  all  of  its  genes
(Christensen, 2016). This virus was shown not to be associated with multiple sclerosis,
but this specific virus has not been thoroughly studied in schizophrenia (Christensen,
2016). The HERV-W family has demonstrably been associated with schizophrenia, but
HERV-K113 does not show any sequence similarity with any HERV-W genome (data
not shown) and are not closely related sequences and likely derive from different ancestor
viruses (Hohn, Hanke, & Bannert, 2013). Whether or not the mechanisms by which they
exert pathogenic effects are similar is unknown. Gene ontology analysis indicates that
differential expression of terms relating to viral response occurred in the tissues studied,
suggesting HERV-K113 particles could have been present, an ability not shared by all
HERV sequences. If viral particles were present, the immune response itself could have
contributed to symptoms in the schizophrenic patient. 
4.4 Links Between Hypoxia, Viruses, and Schizophrenia
These results  show a possibility  of  a  synergistic  effect  between viruses and hypoxia,
leading to the pathoetiology of schizophrenia in this patient. Viral proteins have been
shown to  induce  a  hypoxic  response  through  various  mechanisms,  both  directly  and
indirectly.  Hepatitis  B virus  X protein  interacts  directly  with  HIF-1alpha,  leading  to
increased VEGF expression (Moon et al., 2004). The VACV protein C16 of Vaccinia
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stabilizes PHD2, blocking the normal degradation pathway of HIF-1alpha (Mazzon et al.,
2013). HIV has been shown to indirectly induce transcriptional activity in relation to
hypoxia without interacting with the HIF-1alpha protein. The Vpr protein of HIV has
been shown to activate ROS1 transcription, leading to an increase of oxygen free radicals
and the induction of the hypoxic response; it also interacts with the MAPK and TNFalpha
pathways that also affect hypoxic transcriptional activity (Deshmane et al., 2009). While
HERV-K113 shows high sequence similarity with the HIV genome, this correlates to the
reverse polymerase region of HIV and not Vpr (data not shown). 
4.5 Future Directions
Due to multiple  roles of VEGF in neural tissue beyond angiogenesis,  such as
enhancing neural plasticity and affecting memory and learning, further exploration of the
alternate  splicing  of  VEGFA  would  be  of  interest.  Transcriptional  data  from MISO
indicates  that  the  distribution  of  transcripts  runs  counter  to  previously  reported
prevalence  of  isoforms.  Additional  information  on  the  specific  symptomatology  of
schizophrenic samples could reveal connections between symptoms relating to executive
function  and VEGF regulation.  Further  examination  of  downstream targets  of  VEGF
signaling is warranted to clarify any regulatory changes. Unfortunately, transcriptional
data would not be able to reveal any post translational regulation of VEGF, especially as
many of the VEGF transcripts detected in both samples were for isoforms that require
post  translational  cleavage  to  become  active.  As  a  target  of  HIF-1  and  the
hypoxia/ischemia response, care would be needed in studying patients who died of issues
relating to asphyxiation. 
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The  virus  detected,  HERV-K113,  has  not  been  demonstrably  associated  with
schizophrenia,  however  other  HERV  viruses  have  a  strong  association  with
schizophrenia. Using bioinformatic tools to study transcribed HERV sequences is still in
its  infancy.  Most  studies  referenced here  have  used  quantitative  PCR to  confirm the
presence of viral transcripts in various tissues, targeting specific viral sequences. RNAseq
data  offers  a  broader  view  and  the  possibility  of  detecting  additional  proteins  and
multiple HERV events rather than specifying a specific transcript of interest. As HERVs
are highly heterogeneous sequences, using a tool such as VirusFinder2 that customize
genomes  in  order  to  more  accurately  detect  viruses  could  detect  mutations  in  viral
sequences that may be associated with pathology. Integration analysis using the same
tools  could possibly reveal  deleterious  transposition events  and assist  in  studying the
highly polymorphic character of HERV-K(HML-2) viruses. A larger sample pool would
be  required  to  demonstrate  further  associations  between  HERV  sequences  and
schizophrenia. Combining viral detection data with differential expression analysis by the
Cufflinks  workflow  could  also  reveal  regulatory  events  by  viral  sequences  that
contributed to schizophrenia in this sample pool. 
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